✦ LIBER ✦

Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin

✍ Scribed by Joan A. Stratton; Paul R. Kucera; Mark A. Rettenmaier; Kazuyoshi Dobashi; John P. Micha; Patricia S. Braly; Michael L. Berman; Philip J. DiSaia

Book ID: 119052618
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 623 KB
Volume: 25
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(86)90081-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RANDOMISED COMPARISON OF CISPLATIN WITH

RANDOMISED COMPARISON OF CISPLATIN WITH CYCLOPHOSPHAMIDE/CISPLATIN AND WITH CYCLOPHOSPHAMIDE/DOXORUBICIN/ CISPLATIN IN ADVANCED OVARIAN CANCER

✍ Ginecologia, ; Interegionale, Gruppo; Oncologico, Cooperativo 📂 Article 📅 1987 🏛 The Lancet 🌐 English ⚖ 965 KB

Randomised trial comparing combinations

Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4′-epi-doxorubicin in the treatment of advanced ovarian cancer

✍ Z. Hernádi; B. Juhász; R. Póka; L.G. Lampé 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 563 KB

Phase II Trial of Intraperitoneal Cispla

Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer—Long-Term Follow-Up

✍ Robert J. Morgan Jr.; Patricia Braly; Gary Cecchi; Lucille Leong; Stephen Shibat 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Efficacy and safety of high-dose cisplat

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

✍ Francesco Re; Silvia Bohm; Saro Oriana; Gian Battista Spatti; Franco Zunino 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 655 KB

Dose intensive combination platinum and

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer

✍ Jeremy D. Shapiro; Mace L. Rothenberg; Gisele A. Sarosy; Seth M. Steinberg; Debr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## BACKGROUND. The authors combined cisplatin and carboplatin together with cyclophosphamide to maximize platinum dose intensity in patients with advanced epithelial ovarian cancer (AOC). ## METHODS. The authors treated 26 consecutive, newly diagnosed patients with International Federation of G

Cyclophosphamide-cisplatin/CPM-CDDP/vers

Cyclophosphamide-cisplatin/CPM-CDDP/versus cyclophosphamide-carboplatin/CPM-CPL/ with and without antiemetic zofran in the treatment of advanced ovarian cancer/ST.III–IV

✍ Krommer, K. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB